
Samaya Pharmaceuticals Private Limited
Founded in 2020 and headquartered in Delhi, India.
Founded in 2020 and headquartered in Delhi, India.
North East Delhi, Delhi, India
+91-XXXXXXXXXX
U36999DL2020PTC366913
366913
Private Limited Indian Non-Government Company
27 Jul 2020
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vivek Bharadwaj ![]() | Director | 27-Jul-2020 | Current |
Kushagra Tyagi ![]() | Director | 27-Jul-2020 | Current |
Ankur Tyagi ![]() | Director | 27-Jul-2020 | Current |
Enhance accessibility to Samaya Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Samaya Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Ankur Tyagi is a mutual person
Ankur Tyagi is a mutual person
Ankur Tyagi is a mutual person
There are no open charges registered against the company as per our records.
Samaya Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Samaya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samaya Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ankur Kumar Tyagi was appointed as a Director was appointed as a Director on 27 Jul 2020 & has been associated with this company since 4 years 9 months .
Vivek Bharadwaj was appointed as a Director was appointed as a Director on 27 Jul 2020 & has been associated with this company since 4 years 9 months .
Kushagra Tyagi was appointed as a Director was appointed as a Director on 27 Jul 2020 & has been associated with this company since 4 years 9 months .
Samaya Pharmaceuticals Private Limited was registered on 27 Jul 2020 with Roc Delhi & aged 4 years 9 months as per MCA records.
Samaya Pharmaceuticals Private Limited was incorporated on 27 Jul 2020.
The authorized share capital of Samaya Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 3 directors are associated with Samaya Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Samaya Pharmaceuticals Private Limited is C-56A Ground Floor Khasra No 400, Gali No 2/1 Thana Road Bhajanpura, Delhi East Delhi, India, 110053.
The corporate identification number (CIN) of Samaya Pharmaceuticals Private Limited is U36999DL2020PTC366913 and the company number is 366913 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.